版本:
中国

BRIEF-Redhill Biopharma Ltd and IntelGenx announce RIZAPORT commercialization with pharmatronic co.

Sept 21 Redhill Biopharma Ltd :

* Redhill Biopharma and IntelGenx announce RIZAPORT commercialization term sheet with Pharmatronic Co. for Korea

* Pursuant to signing of definitive agreement, Co will grant Pharmatronic exclusive rights to commercialize RIZAPORT in South Korea

* Under term sheet, Co and IntelGenx are to receive an upfront payment and will be eligible to receive additional milestone payments

* Financial terms of term sheet were not disclosed Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐